| 
    Gov. Blagojevich offers Connecticut help 
    setting up prescription drug importation program    
    
   Send a link to a friend 
            
            [JAN. 21, 2005]  
            CHICAGO -- Gov. Rod 
            Blagojevich announced on Thursday his full support of Connecticut 
            lawmakers' effort to help their citizens import safe, affordable 
            prescription drugs from Canada and Europe and offered to help in any 
            way possible. Connecticut's proposed plan is similar to Gov. 
            Blagojevich's I-SaveRx program, which was the first state-sponsored 
            program in the nation to allow residents to import prescription 
            drugs from state-inspected and approved suppliers in Canada, Ireland 
            and the United Kingdom.  | 
        
          | "We launched I-SaveRx to help our 
            seniors and working families get the medications their doctors say 
            they need, but at prices they can afford," Gov. Blagojevich said. 
            "Too often, people in the United States are forced to choose between 
            paying for groceries or paying for their medicine -- they can't 
            afford both. The federal government has failed to act, and states 
            across the nation are starting to address the problem on their own. 
            I am encouraged and in full support of Connecticut's effort to 
            import prescription drugs from Canada and Europe. We are eager to 
            share the research and expertise we've gained from launching the I-SaveRx 
            program." Illinois first began 
            exploring the feasibility of drug importation in September of 2003, 
            when the governor commissioned a study on the pharmaceutical system 
            in Canada. In the spring of 2004, the governor expanded the review 
            to Europe as well. Public health and regulatory experts from the 
            state researched the pharmaceutical systems in Canada and western 
            Europe to determine if the systems were safe and if Illinoisans 
            could realize significant savings by purchasing medications from 
            foreign sources. In August 2004, the governor's prescription drug 
            advocates released their final report indicating that -- like Canada 
            -- the European prescription drug system was well-regulated and was 
            able to provide the same medications available in the United States 
            at much lower prices. 
            [to top of second column in
this article]
 
             
             |  
            
             Connecticut's proposal would allow 
            residents to import prescription drugs from Canada and Europe 
            through a foreign pharmaceutical benefits manager. The I-Save Rx 
            program works in the same fashion. Illinois and its partner states 
            have contracted with a Canadian pharmaceutical benefits manager to 
            maintain the network of more than 60 approved pharmacies and to 
            administer the program. The benefits manager oversees multiple 
            safeguards that have been put in place to ensure the authenticity 
            and safety of imported prescription drugs.  Gov. Blagojevich launched I-SaveRx 
            on Oct. 4, 2004, and extended an invitation to other states to join 
            the program. Participants in the I-SaveRx plan can save an average 
            of 25 percent to 50 percent on the cost of the most common 
            name-brand medications used to treat chronic conditions.  Residents of Illinois, Wisconsin, 
            Missouri and Kansas can begin the enrollment process or get more 
            information by visiting 
            http://www.i-saverx.net/ or calling the toll-free number 1 (866) 
            ISAVE-33 [1 (866) 472-8333]. The 
            clearinghouse provides users with information on the list of 
            medications included in the program, prices in each of the three 
            countries, and enrollment forms and guidance.  
            [News release from the 
            governor's office] 
            
             |